Touchstone International Medical Science Co., Ltd. (SHA:688013)
China flag China · Delayed Price · Currency is CNY
35.80
+0.03 (0.08%)
May 8, 2026, 3:00 PM CST

SHA:688013 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
326.73272.34253.6231.73213.74
Other Revenue
-0.030.040.310
326.73272.37253.65232.03213.74
Revenue Growth (YoY)
19.96%7.38%9.31%8.56%30.85%
Cost of Revenue
117.87113.64111.899.891.27
Gross Profit
208.86158.73141.85132.23122.47
Selling, General & Admin
81.7774.6671.961.6662.37
Research & Development
51.335.9935.3234.7529.28
Other Operating Expenses
0.161.794.752.392.13
Operating Expenses
133.23112.38112.2798.9794.05
Operating Income
75.6346.3429.5833.2728.41
Interest Expense
--0.23-0.09-0.16-
Interest & Investment Income
2.779.128.034.7611.15
Currency Exchange Gain (Loss)
--0.012.473.944
Other Non Operating Income (Expenses)
8.07-0.171.89-0.12-0.06
EBT Excluding Unusual Items
86.4755.0641.8841.6943.51
Gain (Loss) on Sale of Investments
8.48-1.894.062.090.44
Gain (Loss) on Sale of Assets
0.41-000.020.52
Asset Writedown
-0.19----
Legal Settlements
-----1.08
Other Unusual Items
-1.662.012.282.71
Pretax Income
95.1754.8347.9546.0846.09
Income Tax Expense
9.982.940.642.894.67
Net Income
85.1951.8947.3143.241.42
Net Income to Common
85.1951.8947.3143.241.42
Net Income Growth
64.15%9.69%9.53%4.29%18.52%
Shares Outstanding (Basic)
8080798080
Shares Outstanding (Diluted)
8181828281
Shares Change (YoY)
0.05%-0.60%0.09%0.35%25.49%
EPS (Basic)
1.060.650.600.540.52
EPS (Diluted)
1.050.640.580.530.51
EPS Growth
64.06%10.35%9.43%3.92%-5.56%
Free Cash Flow
-18.7611.4764.542.7351.77
Free Cash Flow Per Share
-0.230.140.790.030.64
Dividend Per Share
-1.000-0.2500.200
Dividend Growth
---25.00%-
Gross Margin
63.92%58.28%55.92%56.99%57.30%
Operating Margin
23.15%17.02%11.66%14.34%13.29%
Profit Margin
26.07%19.05%18.65%18.62%19.38%
Free Cash Flow Margin
-5.74%4.21%25.44%1.18%24.22%
EBITDA
87.555.5338.6341.3535.64
EBITDA Margin
26.78%20.39%15.23%17.82%16.67%
D&A For EBITDA
11.879.199.058.097.22
EBIT
75.6346.3429.5833.2728.41
EBIT Margin
23.15%17.02%11.66%14.34%13.29%
Effective Tax Rate
10.49%5.36%1.33%6.27%10.14%
Revenue as Reported
-272.37253.65232.03213.74
Source: S&P Global Market Intelligence. Standard template. Financial Sources.